Clinical reference lab market seen growing to $29.87 billion by 2030
The clinical reference laboratory service market is projected to rise from $18.98 billion in 2025 to $20.83 billion in 2026, with North America leading and Asia-Pacific growing fastest. The Business Research Company says demand is being driven by personalized medicine, genomic testing, automation and outsourced diagnostics.
Why it matters: - Clinical reference labs support complex diagnostic testing that hospitals and smaller labs often cannot do in-house. - The market’s expansion reflects rising demand for specialized testing tied to personalized medicine, genomics and faster diagnostics. - The forecast points to more outsourcing of lab work and more investment in centralized testing capacity.
What happened: - The Business Research Company released a 2026 report on the global clinical reference laboratory service market. - The market is projected to grow from $18.98 billion in 2025 to $20.83 billion in 2026. - The report forecasts the market will reach $29.87 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.
The details: - The report says historical growth has been driven by outsourcing of diagnostic tests, expanded centralized laboratory networks, stronger demand for specialized diagnostics, increased hospital referral testing and lab technology advances. - The forecast period is supported by broader adoption of precision medicine diagnostics, growth in genomic and molecular testing, more investment in laboratory automation, higher demand for high-throughput testing and wider use of digital workflow platforms. - Key trends include more centralized high-complexity testing, greater reliance on automated laboratory systems, rising demand for genetic and specialized testing, expanded laboratory information systems, and stronger regulatory compliance and quality assurance. - Clinical reference laboratory services are specialized labs that provide diagnostic analyses for healthcare providers, hospitals, clinics and smaller laboratories. - These labs handle complex and specialty tests that are less common in smaller or onsite hospital labs. - The market report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated visuals. - The company also offered a free sample of the report and the full market report.
Between the lines: - Personalized medicine is becoming a bigger driver of lab demand because treatment decisions increasingly depend on genetic and molecular information. - The report points to a market shifting toward centralized, automated and digitally integrated testing models. - Regional growth is likely to follow healthcare spending and adoption of advanced diagnostics, which helps explain the gap between North America’s current lead and Asia-Pacific’s faster growth outlook.
What's next: - The market is expected to keep expanding as precision medicine, genomic testing and laboratory automation move deeper into routine care. - Lab providers are likely to focus on higher-throughput systems and workflow integration to meet demand. - Regulatory compliance and quality assurance should remain a bigger priority as testing volumes and complexity increase.
The bottom line: - Clinical reference laboratories are moving from a support function to a core part of advanced diagnostics, and the market is projected to keep growing through 2030.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Asia Business Gazette
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.